Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,219
datasets available to search
ShareScore release 0.9.0
Dataset results
1,219 results for “randomisation”
Dataset: effect estimates obtained from randomised and non-randomised studies
<p>This dataset provides study-level information on matched sets of published randomised and non-randomised studies answering the same clinical questions. The dataset includes 346 meta-analyses, and data on over 2,700 unique studies.</p> <p>The dataset includes the following information (definitions and coding are provided in the spreadsheet):</p> <ul> <li>IDs for clinical topics and source meta-analyses</li> <li>IDs for individual studies</li> <li>Brief descriptions of clinical topics</li> <li>Therapeutic area (ATC Code first level)</li> <li>Topic narrowness categorical</li> <li>Indicators for high-quality source meta-analyses (Cochrane review; top journal)</li> <li>Time period</li> <li>Comparator type</li> <li>Outcome type</li> <li>Meta-analysis-level median risk of bias for NRS and RCT</li> <li>Publication year of individual studies</li> <li>Risk of Bias in individual studies</li> <li>Standardised effect estimates (logOR) and variance for each study</li> <li>Summary logOR and variance for NRS and RCT, respectively, within each meta-analysis for the full sample</li> </ul> <p>The protocol for this study was registered on PROSPERO: </p> <p>Maximilian Salcher-Konrad. Comparison of treatment effects in randomised vs. non-randomised studies and the role of analytical methods to control for confounding: a meta-epidemiological study. PROSPERO 2018 CRD42018062204 Available from: <a href="https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018062204">https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018062204</a></p>
Supplementary file 48 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 48: Proportion of patients on methylphenidate with agitation</p>
Supplementary file 51 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 51: Proportion of patients on methylphenidate with sleep disorder</p>
Supplementary file 47 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 47: Proportion of patients on methylphenidate with isolation</p>
Supplementary file ROBINS-I Risk of Bias table in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies.
<p>ROBINS-I Risk og Bias Table</p>
Supplementary file 19 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 19 Proportion of patients on methylphenidate with asthenia </p>
Supplementary file 13 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 13: Proportion of patients on methylphenidate with tachycardia </p>
Supplementary dataset for 'A randomised phase III trial of carboplatin compared with docetaxel in BRCA1/2 mutated and pre-specified triple negative breast cancer "BRCAness" subgroups: the TNT Trial'
<p>This dataset corresponds to the PAM50 gene expression profiling of primary tumour samples that were collected as part of the TNT clinical trial (ISRCTN97330959, NCT00532727, CRUK/07/012). NanoString® platform nCounter analysis was performed on the RNA extracts at the Institute of Cancer Research and Royal Marsden Hospital. The manuscript describing the trial outcome is currently under review in Nature Medicine.</p>
Supplementary file 80 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 80: Proportion of participants on methylphenidate with rhinitis</p>
Supplementary file 77 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 77: Proportion of participants on methylphenidate with pharyngitis</p>
Supplementary file 75 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 75: Proportion of participants on methylphenidate with allergies</p>
Supplementary file 74 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 74: Proportion of participants on methylphenidate with pyrexia</p>
Supplementary file 70 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 70: Proportion of participants on methylphenidate with dyspepsia </p>
Supplementary file 79 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 79: Proportion of participants on methylphenidate with with rash</p>
Supplementary file 69 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 69: Proportion of participants on methylphenidate with vomiting </p>
Supplementary file 68 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 68: Proportion of participants on methylphenidate with upset stomach</p>
Supplementary file 83 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 83: Proportion of participants on methylphenidate with skin problems</p>
Supplementary file 76 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 76: Proportion of participants on methylphenidate with cold symptoms </p>
Supplementary file 62 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 62: Proportion of participants on methylphenidate with decreased appetite </p>
Supplementary file 60 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 60: Proportion of participants on methylphenidate with abdominal pain</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.